1E), as expected (Ramos et al., 1998 (Ramos et al., , 2000 . Thus, PEAResults 15 blocks the capacity of ERK to phosphorylate nuclear substrates and activate transcription, but does not im-PEA-15 Blocks Phosphorylation of Nuclear pair the activation or the enzymatic activity of ERK. but Not Cytoplasmic ERK Substrates We previously identified PEA-15 by its blockade of Rasinduced suppression of integrin activation. To examine PEA-15 Blocks ERK Translocation to the Nucleus These studies suggested that PEA-15 might impair ERK the effects of PEA-15 on other targets of the MAP kinase pathway, we assessed its effects on the phosphorylation nuclear translocation. To test this possibility, we assessed the nuclear localization of ERK in cells expressof nuclear and cytoplasmic ERK substrates. Expression of PEA-15 markedly inhibited serum-stimulated phosing high levels of PEA-15. The PEA-15 was tagged with GFP so that its localization could be examined simultaphorylation of the nuclear substrate, Elk-1 ( Figure 1A ), but had no effect on phosphorylation of the cytoplasmic neously with ERK. Immunofluorescence revealed that ERK was largely confined to the cytosol in PEA-15-substrate, stathmin ( Figure 1B ) or p90RSK (data not shown). The inhibition of phosphorylation of nuclear transfected cells. The addition of 20% serum failed to stimulate nuclear localization (Figure 2A ). In cells transsubstrates resulted in abrogation of ERK-stimulated transcriptional activation of Elk-1 ( Figure 1C ). Suppresfected with GFP alone, ERK localization was largely nuclear in serum-stimulated cells and predominantly cytosion of serum response element-dependent transcription was also observed (data not shown). PEA-15 did plasmic in serum-starved cells (Figure 2A ). PEA-15 was restricted to the cytoplasm in the presence or absence not block ERK kinase activity because addition of exogenous PEA-15 to purified, activated ERK failed to block of serum ( Figure 2B ). In order to confirm and quantify these immunofluorescence results, subcellular fractionrecombinant Elk-1 phosphorylation in vitro ( Figure 1D ). On the contrary, PEA-15 enhanced and prolonged the ation experiments were performed. In serum-stimulated, PEA-15-transfected cells, less than 22% of ERK 1 and serum-stimulated activation of ERK MAP kinase ( Figure 2 were in the nucleus. In sharp contrast, in control cells, 56% of ERK 1 and 2 were in the nucleus ( Figure 2C) . Thus, increased expression of PEA-15 results in impaired ERK translocation to the nucleus.
PEA-15, at Physiological Abundance, Regulates ERK Signaling As described above, we found that forced expression of PEA-15 resulted in impaired ERK translocation to the nucleus. As previously noted, PEA-15 is highly expressed in astrocytes, cells that are normally quiescent in vivo. To further assess the role of PEA-15 in ERK signaling under physiological conditions, we examined the proliferative response of PEA-15 null and wild-type astrocytes. The PEA-15 null astrocytes showed a marked increase in tritiated thymidine incorporation in 0.2% or 10% serum. In the presence of 10% serum, tritiated thymidine incorporation was approximately 3-fold greater in the null cells as compared to the PEA-15-expressing cells ( Figure 3A) . Furthermore, this increase in thymidine incorporation was associated with an increased serum response element-dependent cFos transcription ( Figure 3B ). In addition, lack of PEA-15 led to an increased proliferation rate as reflected by increases in cell number ( Figure 3C ). These changes in proliferative response in the PEA-15 null cells were associated with an alteration in the nuclear localization of ERK. Thus, even in the presence of 0.2% serum, ERK was largely localized to the nucleus in the PEA-15 null cells. In contrast, in PEA-15-expressing cells, nuclear localization was only observed in the presence of 20% serum ( Figure 3D ). In spite of these differences in nuclear localization, there was little difference in the extent of ERK activation in the wild-type and knockout cells in 0.2% or 20% serum (data not shown). To determine whether these differences between PEA-15 null and wild-type cells were as a direct consequence of the loss of PEA-15 expression, we reconstituted the null astrocytes with PEA-15 and examined ERK localization. As expected, ERK no longer accumulated in the nucleus of these cells ( Figures 3E and 3F Figure 4D ). In-ERK 2 were identified. Since ERK 1 clones differed in the length of their 5Ј-untranslated region, they represented deed, this mutant appeared to increase nuclear ERK relative to cells transfected with control vector DNA. independent clones; however, all were in frame with the GAL4 activation domain of the vector, pACTII. All ERK These results demonstrate that PEA-15 is excluded from the nucleus due to an NES located at its N terminus.
clones failed to interact with the unrelated protein, lamin, or vector controls ( Figure 5A ). The binding of PEA-15 Furthermore, cytoplasmic localization of PEA-15 is required for its capacity to sequester ERK in the cytowas specific to ERK among the components of the ERK MAP kinase pathway, since PEA-15 failed to interact plasm. with Ras, Raf1, or MEK1 ( Figure 5B) . Moreover, the assowere recovered from both lysates ( Figure 6A ). Moreover, Western blotting with an antibody specific to phosphorciation was due to a specific interaction with PEA-15, ylated ERK 1 and 2 confirmed that both phosphorylated since no interaction could be detected with PEA-15's and unphosphorylated ERK 1 and 2 bound equally well DED alone, or with another death effector domain proto PEA-15 ( Figure 6A ). Furthermore, a kinase-inactive, tein, FADD ( Figure 5B) . T192A, mutant of ERK 1 bound as well to PEA-15 as a In order to confirm this interaction biochemically, a wild-type ERK 1 ( Figure 6B) . Thus, the activation state purified PEA-15-GST fusion was prepared, and cellular of ERK does not influence its interaction with PEA-15. proteins that bound from a lysate of 3T3 cells were Since PEA-15 has at least two serine phosphorylation analyzed by Western blotting. PEA-15 specifically sites, we asked whether ERK could phosphorylate PEAbound native ERK 1/2 but not the related MAP kinases 15. Purified activated ERK efficiently phosphorylated the p38 or JNK ( Figure 5D ). Furthermore, purified recombinuclear transcription factor Elk-1, but failed to phosnant ERK 2 bound directly to immobilized PEA-15 ( for its ability to enforce cytoplasmic sequestration of ERK and to impair ERK-dependent transcription and cell proliferation.
Discussion
Precise regulation of the ERK MAP kinase pathway is essential for the growth and survival of eukaryotic cells. We found that PEA-15 blocks ERK phosphorylation of nuclear but not cytoplasmic substrates and ERK-dependent transcription. Furthermore, at physiological, but high, abundance, PEA-15 limits the nuclear translocation of ERK and cell proliferation in astrocytes. PEA-15 does not impair the activation of ERK nor does it inhibit ERK kinase activity. Instead, PEA-15 binds to ERK, removing it from the nucleus in a manner dependent on the PEA-15 nuclear export sequence (NES). In consequence, PEA-15 modifies signaling in the MAP kinase pathway by enforcing cytoplasmic localization of ERKs.
PEA-15 alters the output of ERK signaling without blocking ERK activation. PEA-15 blocks MAP kinase regulation of integrins without impairing ERK activation (Ramos et al., 1998) . We now report that PEA-15 blocks the phosphorylation of ERK substrates in the nucleus but not the cytoplasm with consequent inhibition of ERK-dependent transcription. Moreover, we found that physiological levels of PEA-15, expressed in cultured astrocytes, can restrict ERK to the cytoplasm and block ERK-dependent cFos transcription and cell proliferation (Figures 3 and 7) . PEA-15 is particularly enriched in ma- also inhibits cell proliferation. Thus, this observation supports the hypothesis that ERK phosphorylation of nuclear transcription factors is required for cell prolifera-C-terminal portion. Neither isolated domain bound ERK well ( Figure 7B ). Furthermore, we previously found that a tion (Cobb, 1999) . In addition, PEA-15 blocks the capacity of activated Ras to suppress integrin activation, sugmutation in a conserved Asp (D74A) in the death effector domain of PEA-15 reduces its ability to reverse MAP gesting a possible role for nuclear localization of ERK in this process ( 
